|
HRTX
|
Heron Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
HLVX
|
HilleVax, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
GLUE
|
Monte Rosa Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
FULC
|
Fulcrum Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
FHTX
|
Foghorn Therapeutics Inc.
|
0.00%
|
US
|
NASDAQ
|
|
ERAS
|
Erasca, Inc
|
0.00%
|
US
|
NASDAQ
|
|
CMAX
|
CareMax, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
CINC
|
CinCor Pharma, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
AVTE
|
Aerovate Therapeutics, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
AVAH
|
Aveanna Healthcare Holdings Inc.
|
0.00%
|
US
|
NASDAQ
|
|
AMRX
|
Amneal Pharmaceuticals, Inc.
|
0.00%
|
US
|
NYSE
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
0.00%
|
US
|
NASDAQ
|
|
AKYA
|
Akoya BioSciences, Inc.
|
0.00%
|
US
|
NASDAQ
|
|
QSI
|
Quantum-Si
|
0.00%
|
US
|
NASDAQ
|
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
0.00%
|
US
|
NASDAQ
|